Evidence map›Paper›PMID 38733186›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Inhibitory effect of small-molecule compound AM679 targeting elongation-factor binding protein 2 on hepatitis B virus in vitro].

H J Fang, J Y Cai, X X Hou, J L Song, L Y Peng, C L Zhu

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H J FangDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
J Y CaiDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
X X HouDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
J L SongDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
L Y PengDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
C L ZhuDepartment of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.

Funding

Jiangsu Province Capability Improvement Project through Science, Technology and Education JSDW202207National Natural Science Foundation of China 81770591
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis B virusVirus ReplicationDNA, ViralGuanineHepatitis B e AntigensHepatitis B Surface AntigensHep G2 CellsHumansIndolesPentanoic AcidsPeptide Elongation FactorsRibonucleoprotein, U5 Small Nuclear3-(5-(-1-acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-(4-(5-methoxypyrimidin-2-yl)-benzyl)-1H-indol-2-yl)-2,2-dimethyl-propionic acidAntiviral AgentsDNA, ViralEFTUD2 protein, humanentecavirGuanineHepatitis B e AntigensHepatitis B Surface AntigensIndolesPentanoic AcidsPeptide Elongation FactorsRibonucleoprotein, U5 Small NuclearAM679EFTUD2Hepatitis B virusSmall molecule compound

Identifiers

PMID38733186
PMCPMC12677322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.